Showing results (441-450 of 618) with videos related to

Sort By:
Pageof 62
European Journal of Cell Biology|October 1, 1992
Fibronectin cleavage fragments provide a growth factor-like activity for the differentiation of Trypanosoma cruzi trypomastigotes to amastigotesA Ouaissi, J Cornette, R Schöneck, et al.
Peptide Research|January 1, 1991
Epitopic characterization and vaccinal potential of peptides derived from a major antigen of Schistosoma mansoni (Sm28 GST)C Auriault, I Wolowczuk, H Gras-Masse, et al.
The Journal of Clinical Investigation|February 1, 1992
Diagnostic value of a synthetic peptide derived from Echinococcus granulosus recombinant proteinM Chamekh, H Gras-Masse, M Bossus, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1991
Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reactionP Gosset, A Tsicopoulos, B Wallaert, et al.
European Journal of Immunology|May 1, 1991
Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunitJ Plumas, V Gruart, D Aldebert, et al.
International Archives of Allergy and Immunology|May 1, 1997
Differentiation of eosinophils from cord blood cell precursors: kinetics of Fc epsilon RI and Fc epsilon RII expressionM Capron, M Morita, G Woerly, et al.
Journal of Biomolecular Structure & Dynamics|September 24, 1998
Molecular modeling of HIV-1 coreceptor CCR5 and exploring of conformational space of its extracellular domain in molecular dynamics simulationR G Efremov, F Legret, G Vergoten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Immunologic response of athymic rats to Schistosoma mansoni infection. II. Antibody-dependent mechanisms of resistanceM Capron, A Capron, S K Abdel-Hafez, et al.
Biochimica Et Biophysica Acta|August 15, 1987
Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human plateletC Bronner, C Wiggins, D Monté, et al.
Journal of Virology|August 10, 2000
The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cellsE C Darcissac, M J Truong, J Dewulf, et al.
Pageof 62